본문 바로가기
KERD
논문KCI 등재

산후갑상선염에 동반된 그레이브스병 2예

Two Cases of Postpartum Thyroiditis Followed by Graves’ Disease

한은진|임창훈|양지훈
대한갑상선학회 (Korean Thyroid Association)|2013.05|International Journal of Thyroidology|제6권 제1호|pp. 75-79

1

조회

0

다운로드

1

인용

0

참고문헌

키워드

ThyrotoxicosisGraves’ disease그레이브스병갑상선중독증산후갑상선염Postpartum thyroiditis
주제분류의학일반

초록

The most common thyroid dysfunctions that occur after delivery are postpartum thyroiditis (PPT) and Graves' disease (GD). PPT is more likely to occur among patients who had a history of PPT or GD. For that reason, it is possible to assume that both PPT and GD occur concomitantly after delivery. Here we report two cases of atypical postpartum thyroid dysfunctions presenting the simultaneous occurrence of PPT and GD. A 31-year-old woman with history of PPT had thyrotoxicosis and hypothyroidism of PPT followed by GD with mild symptoms. The patient recovered quickly afterwards. In the second case, a 28-year-old woman with a history of GD presented with thyrotoxicosis of PPT followed by severe GD. The patient required long-term antithyroid treatment.

Abstract

The most common thyroid dysfunctions that occur after delivery are postpartum thyroiditis (PPT) and Graves' disease (GD). PPT is more likely to occur among patients who had a history of PPT or GD. For that reason, it is possible to assume that both PPT and GD occur concomitantly after delivery. Here we report two cases of atypical postpartum thyroid dysfunctions presenting the simultaneous occurrence of PPT and GD. A 31-year-old woman with history of PPT had thyrotoxicosis and hypothyroidism of PPT followed by GD with mild symptoms. The patient recovered quickly afterwards. In the second case, a 28-year-old woman with a history of GD presented with thyrotoxicosis of PPT followed by severe GD. The patient required long-term antithyroid treatment.

참고문헌 (41)

  1. Vasileiadis I, "Papillary thyroid microcarcinoma: clinicopathological characteristics and implications for treatment in 276 patients", Eur J Clin Invest, 42(6), pp.657~664 (2012)
  2. 이남섭, "갑상선 미세유두상암에서 림프절 전이의 위험인자", 대한외과학회지, 78(2), pp.82~86 (2010), 대한외과학회
  3. Sobin LH, "International Union Against Cancer. TNM classification of malignant tumours" (2010), Wiley-Blackwell
  4. Davies L, "Increasing incidence of thyroid cancer in the United States, 1973-2002", JAMA, 295(18), pp.2164~2167 (2006)
  5. Lo CY, "Papillary microcarcinoma: is there any difference between clinically overt and occult tumors?", World J Surg, 30(5), pp.759~766 (2006)
  6. Ito Y, "An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid", Thyroid, 13(4), pp.381~387 (2003)
  7. Chow SM, "Papillary microcarcinoma of the thyroid-Prognostic significance of lymph node metastasis and multifocality", Cancer, 98(1), pp.31~40 (2003)
  8. Yi KH, "Revised Korean Thyroid Association Management Guidelines for patients with thyroid nodules and thyroid cancer", Korean J Otorhinolaryngol-Head Neck Surg, 54(1), pp.8~36 (2011)
  9. Gilliland FD, "Prognostic factors for thyroid carcinoma. A population-based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) program 1973-1991", Cancer, 79(3), pp.564~573 (1997)
  10. Cappelli C, "Aggressiveness and outcome of papillary thyroid carcinoma (PTC) versus microcarcinoma (PMC): a mono- institutional experience", J Surg Oncol, 95(7), pp.555~560 (2007)
  11. Liou MJ, "Renal metastasis from papillary thyroid microcarcinoma", Acta Otolaryngol, 125(4), pp.438~442 (2005)
  12. Ito Y, "Clinical significance of metastasis to the central compartment from papillary microcarcinoma of the thyroid", World J Surg, 30(1), pp.91~99 (2006)
  13. Sipos JA, "Thyroid cancer epidemiology and prognostic variables", Clin Oncol (R Coll Radiol), 22(6), pp.395~404 (2010)
  14. Ito Y, "Relationship between prognosis of papillary thyroid carcinoma patient and age: a retrospective single-institution study", Endocr J, 59(5), pp.399~405 (2012)
  15. Cady B, "An expanded view of risk-group definition in differentiated thyroid carcinoma", Surgery, 104(6), pp.947~953 (1988)
  16. Sugitani I, "A novel classification system for patients with PTC: addition of the new variables of large (3 cm or greater) nodal metastases and reclassification during the follow-up period", Surgery, 135(2), pp.139~148 (2004)
  17. Jin-Kyu Cho, "Clinical features and prognostic factors in papillary thyroid microcarcinoma depends on age", 대한외과학회지, 82(5), pp.281~287 (2012), 대한외과학회
  18. 김보연, "Impact of Clinicopathologic Factors on Subclinical Central Lymph Node Metastasis in Papillary Thyroid Microcarcinoma", Yonsei Medical Journal, 53(5), pp.924~930 (2012), 연세대학교의과대학
  19. Roh JL, "Lateral cervical lymph node metastases from papillary thyroid carcinoma: pattern of nodal metastases and optimal strategy for neck dissection", Ann Surg Oncol, 15(4), pp.1177~1182 (2008)
  20. So YK, "Subclinical lymph node metastasis in papillary thyroid microcarcinoma: a study of 551 resections", Surgery, 148(3), pp.526~531 (2010)
  21. Kim SS, "Coexistence of Hashimoto's thyroiditis with papillary thyroid carcinoma: the influence of lymph node metastasis", Head Neck, 33(9), pp.1272~1277 (2011)
  22. Schaffler A, "Coexistent thyroiditis is associated with lower tumour stage in thyroid carcinoma", Eur J Clin Invest, 28(10), pp.838~844 (1998)
  23. Cooper DS, "Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer", Thyroid, 19(11), pp.1167~1214 (2009)
  24. Loh KC, "Influence of lymphocytic thyroiditis on the prognostic outcome of patients with papillary thyroid carcinoma", J Clin Endocrinol Metab, 84(2), pp.458~463 (1999)
  25. Singh B, "Coexistent Hashimoto's thyroiditis with papillary thyroid carcinoma: impact on presentation, management, and outcome", Surgery, 126(6), pp.1070~1076 (1999)
  26. Shattuck TM, "Independent clonal origins of distinct tumor foci in multifocal papillary thyroid carcinoma", N Engl J Med, 352(23), pp.2406~2412 (2005)
  27. Ito Y, "Papillary microcarcinoma of the thyroid: how should it be treated?", World J Surg, 28(11), pp.1115~1121 (2004)
  28. Ringel MD, "Controversies in the follow-up and management of well-differentiated thyroid cancer", Endocr Relat Cancer, 11(1), pp.97~116 (2004)
  29. Lee X, "Analysis of differential BRAF(V600E) mutational status in high aggressive papillary thyroid microcarcinoma", Ann Surg Oncol, 16(2), pp.240~245 (2009)
  30. Pelizzo MR, "Papillary thyroid microcarcinoma (PTMC): prognostic factors, management and outcome in 403 patients", Eur J Surg Oncol, 32(10), pp.1144~1148 (2006)
  31. Stagnaro-Green A, "Clinical review 152: Postpartum thyroiditis", J Clin Endocrinol Metab, 87(9), pp.4042~4047 (2002)
  32. Amino N, "Postpartum autoimmune thyroid syndrome: a model of aggravation of autoimmune disease", Thyroid, 9(7), pp.705~713 (1999)
  33. Benhaim Rochester D, "Increased risk of Graves' disease after pregnancy", Thyroid, 15(11), pp.1287~1290 (2005)
  34. 임창훈, "출산에 따른 그레이브스병의 재발 및 관련인자", Endocrinology and Metabolism, 17(2), pp.189~196 (2002), 대한내분비학회
  35. Tagami T, "The incidence of gestational hyperthyroidism and postpartum thyroiditis in treated patients with Graves' disease", Thyroid, 17(8), pp.767~772 (2007)
  36. Shigemasa C, "Three patients who spontaneously developed persistent hypothyroidism during or following treatment with antithyroid drugs for Graves' hyperthyroidism", Arch Intern Med, 150(5), pp.1105~1109 (1990)
  37. Nakamura S, "Transient hypothyroidism in a case of untreated Graves' disease", Endocr J, 42(1), pp.77~81 (1995)
  38. Iitaka M, "A case of Graves' disease with false hyperthyrotropinemia who developed silent thyroiditis", Endocrinol Jpn, 38(6), pp.667~671 (1991)
  39. Momotani N, "Relationship between silent thyroiditis and recurrent Graves' disease in the postpartum period", J Clin Endocrinol Metab, 79(1), pp.285~289 (1994)
  40. Iitaka M, "Stimulation of thyroid-stimulating hormone (TSH) receptor antibody production following painless thyroiditis", Clin Endocrinol (Oxf), 60(1), pp.49~53 (2004)
  41. Nagai Y, "Occurrence and spontaneous remission of Graves' hyperthyroidism preceded by painless thyroiditis", Endocr J, 44(6), pp.881~885 (1997)

관련 논문AI추천

아급성 갑상선염 후 발병된 그레이브스병 1예고관표, 김수희, 김지영, 범종욱, 서혜미, 유소연, 이상아대한내과학회 · 대한내과학회지2015 · 제89권 제2호Recurrent Painless Thyroiditis in Patients with History of Postpartum Thyroiditis유원상대한갑상선학회 · International Journal of Thyroidology2018 · 제11권 제1호파행성 아급성 갑상선염 후 발병된 그레이브스병 1예전언주, 정의달대한갑상선학회 · International Journal of Thyroidology2014 · 제7권 제1호Recurrent Hyperthyroidism Following Postpartum Thyroiditis in a Woman with Hashimoto’s Thyroiditis김기호, 김지혜, 송선경대한갑상선학회 · International Journal of Thyroidology2015 · 제8권 제2호The High Proportion of Painless Thyroiditis as a Cause of Thyrotoxicosis in Korea김상진, 김여주, 류아정, 모상일대한갑상선학회 · International Journal of Thyroidology2015 · 제8권 제1호중독성 선종으로 방사성요오드 치료 후 발생한 그레이브스병 1예김민주, 신기철, 윤석영, 조애리대한갑상선학회 · International Journal of Thyroidology2015 · 제8권 제1호

이 간행물의 다른 논문 (11건)

갑상선기능항진증의 진단 및 치료- 대한갑상선학회 합의안이가희, 정재훈, 김인주, 송영기, 이재태, 문재훈, 정웅윤, 범희승pp. 1-11갑상선암 방사성요오드 치료에 관한 환자 안내서- 제 1 판(2012) -정재훈, 김원배, 김민희, 이용상, 이송미, 조영석, 정규환, 천기정, 김병일, 이규언, 석주원, 강성준, 박영주pp. 12-25영상을 이용한 방사핵종 치료의 선량평가임일한pp. 26-33방사성요오드 치료: 경험적 고정용량투여방법에 대한 고찰과 선별적 응용박정미pp. 34-42갑상선암의 방사성요오드 치료에서 선량평가에 기반한 치료용량 결정의 방법과 임상적 유효성팽진철, 정준기pp. 43-48
원문 보기